GoHealth, Inc. (NASDAQ:GOCO) Short Interest Down 8.7% in January

GoHealth, Inc. (NASDAQ:GOCO) saw a significant decrease in short interest in the month of January. As of January 15th, there was short interest totalling 129,400 shares, a decrease of 8.7% from the December 31st total of 141,700 shares. Currently, 1.6% of the company’s shares are short sold. Based on an average trading volume of 38,900 shares, the short-interest ratio is presently 3.3 days.

Analyst Ratings Changes

Separately, Royal Bank of Canada restated a “sector perform” rating and issued a $13.00 target price on shares of GoHealth in a research report on Monday, October 21st.

GoHealth Trading Up 0.5 %

GOCO stock traded up $0.08 during mid-day trading on Friday, hitting $16.30. 18,205 shares of the company were exchanged, compared to its average volume of 62,262. The firm has a market capitalization of $373.43 million, a P/E ratio of -4.66 and a beta of 1.64. The company has a quick ratio of 1.18, a current ratio of 1.18 and a debt-to-equity ratio of 1.72. GoHealth has a 12-month low of $7.27 and a 12-month high of $18.20. The business has a fifty day simple moving average of $13.43 and a 200-day simple moving average of $11.45.

GoHealth (NASDAQ:GOCO) last issued its quarterly earnings results on Thursday, November 7th. The company reported ($3.73) earnings per share for the quarter, missing the consensus estimate of ($3.19) by ($0.54). GoHealth had a negative return on equity of 17.17% and a negative net margin of 4.32%. The company had revenue of $118.29 million for the quarter, compared to analysts’ expectations of $105.93 million. During the same quarter last year, the company earned ($2.61) EPS. On average, equities research analysts predict that GoHealth will post -5.5 earnings per share for the current fiscal year.

Hedge Funds Weigh In On GoHealth

Large investors have recently bought and sold shares of the business. Empowered Funds LLC boosted its holdings in GoHealth by 5.1% in the third quarter. Empowered Funds LLC now owns 22,048 shares of the company’s stock valued at $207,000 after purchasing an additional 1,072 shares in the last quarter. Geode Capital Management LLC raised its stake in GoHealth by 3.2% during the 3rd quarter. Geode Capital Management LLC now owns 103,735 shares of the company’s stock valued at $973,000 after acquiring an additional 3,205 shares during the last quarter. Renaissance Technologies LLC lifted its holdings in shares of GoHealth by 22.0% during the second quarter. Renaissance Technologies LLC now owns 18,272 shares of the company’s stock worth $178,000 after purchasing an additional 3,300 shares during the period. JPMorgan Chase & Co. increased its stake in shares of GoHealth by 99.3% during the third quarter. JPMorgan Chase & Co. now owns 8,437 shares of the company’s stock worth $79,000 after acquiring an additional 4,204 shares during the period. Finally, Barclays PLC increased its position in GoHealth by 83.9% during the 3rd quarter. Barclays PLC now owns 9,580 shares of the company’s stock worth $89,000 after purchasing an additional 4,372 shares during the period. Hedge funds and other institutional investors own 24.21% of the company’s stock.

About GoHealth

GoHealth, Inc operates as a health insurance marketplace and Medicare-focused digital health company in the United States. The company operates a technology platform that leverages machine-learning algorithms of insurance behavioral data to optimize the process for helping individuals find the health insurance plan for their specific needs.